• Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Brokerages

    Source: Buzz FX / 18 Mar 2025 03:51:16   America/Chicago


    Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Brokerages Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Shares of Trevi Therapeutics, Inc.
    Read more...
Share on,